Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR2 | P21802 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20102530 | 0.90 | CTSL (0.34) | FGFR2CTSLCTSSCTSK | |
| SCHEMBL20111337 | 0.86 | GABRA1 (0.33) | FGFR2CTSLCTSSCTSK | |
| SCHEMBL20102404 | 0.85 | CTSL (0.39) | FGFR2CTSLCTSSCTSK | |
| SCHEMBL20102414 | 0.83 | FGFR2 (0.39) | FGFR2 | |
| SCHEMBL20102405 | 0.82 | FGFR2 (0.34) | FGFR2CTSLCTSSCTSK | |
| SCHEMBL20111320 | 0.79 | PTGS1 (0.35) | FGFR2 | |
| SCHEMBL20111247 | 0.79 | L3MBTL1 (0.35) | FGFR2CTSLCTSSCTSK | |
| SCHEMBL10301566 | 0.77 | FFAR4 (0.36) | FGFR2CTSLCTSSCTSK | |
| SCHEMBL20111248 | 0.77 | QRFPR (0.36) | — | |
| SCHEMBL2607229 | 0.75 | KDM4E (0.39) | FGFR2CTSLCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180119009-A1 | LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180119009-A1 | LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | YBX1, PIEZO1, C1S | FGFR2 168/4885CTSL 2729/4885CTSS 2436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.